Loading insider details...
Beta
Latest Form 4 (Oct 17, 2026): Exercise/Conversion of 7,500 XENE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 7,500 | n/a |
| Oct 1, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Purchase | 15,000 | $559.7K |
| Oct 17, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 225,000 | n/a |
| Jun 11, 2024 | Deciphera Pharmaceuticals, Inc. | Grant/Award | 34,157 | n/a |
| Feb 20, 2024 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/Award | 17,275 | n/a |
| Jan 18, 2024 | Deciphera Pharmaceuticals, Inc. (DCPH) | Sale | 2,435 | $35.2K |